Overview
- Gordon Robb, 63, was diagnosed with a haemorrhagic stroke after experiencing a sudden inability to read despite feeling otherwise normal.
- He joined the ASPIRING clinical trial and is receiving clopidogrel as researchers compare it with aspirin to prevent further strokes, heart attacks and premature deaths after haemorrhagic stroke.
- The study is led by University of Edinburgh investigators, funded by the British Heart Foundation, and includes about 4,000 participants worldwide.
- Experts say isolated difficulty recognising written words occurs in fewer than 1% of people at stroke onset, while haemorrhagic strokes account for roughly 15% of all strokes.
- The British Heart Foundation and stroke specialists urge people to seek urgent assessment for sudden, unusual neurological symptoms that fall outside FAST.